Pneumonitis due to Corynebacterium equi.

PubWeight™: 1.12‹?› | Rank: Top 10%

🔗 View Article (PMID 1277942)

Published in Chest on July 01, 1976

Authors

S E Gardner, T Pearson, W T Hughes

Articles by these authors

Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention. Circulation (2000) 5.41

Pneumocystis carinii infection: evidence for high prevalence in normal and immunosuppressed children. Pediatrics (1978) 4.44

Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med (1977) 3.97

Efficacy of trimethoprim and sulfamethoxazole in the prevention and treatment of Pneumocystis carinii pneumonitis. Antimicrob Agents Chemother (1974) 3.86

A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study). Am J Transplant (2010) 3.05

Ampicillin prevents intrapartum transmission of group B streptococcus. JAMA (1979) 3.00

Propagation of Pneumocystis carinii in vitro. Pediatr Res (1977) 2.92

Natural mode of acquisition for de novo infection with Pneumocystis carinii. J Infect Dis (1982) 2.80

AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation (2001) 2.79

Efficacy of diaminodiphenylsulfone and other drugs in murine Pneumocystis carinii pneumonitis. Antimicrob Agents Chemother (1984) 2.54

Prevention of Pneumocystis carinii pneumonitis in AIDS patients with weekly dapsone. Lancet (1990) 2.44

Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia. N Engl J Med (1997) 2.38

Varicella in children with cancer: Seventy-seven cases. Pediatrics (1975) 2.29

Search for primary infection by Pneumocystis carinii in a cohort of normal, healthy infants. Clin Infect Dis (2001) 2.24

Development of murine monoclonal antibodies to Pneumocystis carinii. J Infect Dis (1986) 2.04

Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex. Clin Exp Immunol (2009) 2.00

Comparison of pentamidine isethionate and trimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia. J Pediatr (1978) 1.99

Pneumocystis carinii in vitro: A study by scanning electron microscopy. Am J Pathol (1977) 1.96

Association of primary Pneumocystis carinii infection and sudden infant death syndrome. Clin Infect Dis (1999) 1.94

Studies of morphology and immunofluorescence of Pneumocystis carinii. Proc Soc Exp Biol Med (1972) 1.82

Passive immunoprophylaxis with specific monoclonal antibody confers partial protection against Pneumocystis carinii pneumonitis in animal models. J Clin Invest (1988) 1.78

Evidence of a healthy estrogen user survivor effect. Epidemiology (1995) 1.72

Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer. N Engl J Med (1988) 1.65

Aeromonas hydrophila septicemia. Am J Dis Child (1972) 1.65

Fatal infections in childhood leukemia. Am J Dis Child (1971) 1.59

Limited effect of trimethoprim-sulfamethoxazole prophylaxis on Pneumocystis carinii. Antimicrob Agents Chemother (1979) 1.59

Attempts at prophylaxis for murine Pneumocystis carinii pneumonitis. Curr Ther Res Clin Exp (1973) 1.57

Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56

Propagation of Pneumocystis carinii in Vero cell culture. Infect Immun (1978) 1.55

Protein-calorie malnutrition. A host determinant for Pneumocystis carinii infection. Am J Dis Child (1974) 1.55

Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med (1987) 1.52

Genetic diversity in human-derived Pneumocystis carinii isolates from four geographical locations shown by analysis of mitochondrial rRNA gene sequences. J Clin Microbiol (1994) 1.50

Transmission of Pneumocystis carinii DNA from a patient with P. carinii pneumonia to immunocompetent contact health care workers. J Clin Microbiol (2000) 1.50

Pneumocystis carinii pneumonitis in children with malignancies. J Pediatr (1973) 1.49

Limited persistence in and subsequent elimination of Pneumocystis carinii from the lungs after P. carinii pneumonia. J Infect Dis (1995) 1.47

A myeloma hybrid producing antibody specific for an allotypic determinant on "IgD-like" molecules of the mouse. Eur J Immunol (1977) 1.41

A new look at blockade of T-cell costimulation: a therapeutic strategy for long-term maintenance immunosuppression. Am J Transplant (2006) 1.40

Floppy pinnae in Siamese cats. Vet Rec (1998) 1.39

Normal ranges for packed cell volume and hemoglobin concentration in adults: relevance to "apparent polycythemia". Eur J Haematol (2001) 1.39

Treatment of Pneumocystis carinii pneumonitis with trimethoprim-sulfamethoxazole. Can Med Assoc J (1975) 1.39

Transplanting the highly sensitized patient: The emory algorithm. Am J Transplant (2006) 1.38

Aspergillosis in children with cancer: A 34-year experience. Clin Infect Dis (1999) 1.37

Purification and initial characterization of a ferret Pneumocystis carinii surface antigen. J Infect Dis (1988) 1.35

Some implications of fatal nephritis associated with mumps. Am J Dis Child (1966) 1.34

Fatal Staphylococcus epidermidis sepsis following bone marrow transplantation. Johns Hopkins Med J (1980) 1.31

Histopathology of Pneumocystis carinii infestation and infection in malignant disease in childhood. Hum Pathol (1974) 1.26

Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7  TeV. Phys Rev Lett (2012) 1.23

Intensity of immunosuppressive therapy and the incidence of Pneumocystis carinii pneumonitis. Cancer (1975) 1.22

Current status of laboratory diagnosis of Pneumocystis carinii pneumonitis. CRC Crit Rev Clin Lab Sci (1975) 1.22

Direct measurement of adenosine release during hypoxia in the CA1 region of the rat hippocampal slice. J Physiol (2000) 1.20

Failure of penicillin to eradicate group B streptococcal colonization in the pregnant woman. A couple study. Am J Obstet Gynecol (1979) 1.20

CD40-specific costimulation blockade enhances neonatal porcine islet survival in nonhuman primates. Am J Transplant (2011) 1.19

Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV. Phys Rev Lett (2012) 1.19

Azimuthal anisotropy of charged particles at high transverse momenta in Pb-Pb collisions at sqrt[s(NN)] = 2.76  TeV. Phys Rev Lett (2012) 1.19

AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol (2001) 1.17

Infections in the compromised host. Adv Intern Med (1977) 1.17

The nosocomial colonization of T. Bear. Infect Control (1986) 1.16

Pneumocystis carinii pneumonia. N Engl J Med (1977) 1.16

Prevention of varicella in high risk children: a collaborative study. Pediatrics (1972) 1.16

Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects: the DELTA Study, protocol 1. Arterioscler Thromb Vasc Biol (1998) 1.15

The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers. Br J Cancer (2005) 1.15

From the National Institutes of Health. Summary of the workshop on future directions in discovery and development of therapeutic agents for opportunistic infections associated with AIDS. J Infect Dis (1991) 1.13

Recurrent pneumocystis carinii pneumonia following apparent recovery. J Pediatr (1971) 1.13

Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: medical office assessment: Writing Group I. Circulation (2000) 1.13

Herpes zoster in children with cancer. Am J Dis Child (1973) 1.12

Successful treatment and prevention of murine Pneumocystis carinii pneumonitis with 4,4'-sulfonylbisformanilide. Antimicrob Agents Chemother (1986) 1.12

Validation for MEDFICTS, a dietary assessment instrument for evaluating adherence to total and saturated fat recommendations of the National Cholesterol Education Program Step 1 and Step 2 diets. J Am Diet Assoc (2001) 1.12

A natural source of infection due to pneumocystis carinii. J Infect Dis (1983) 1.11

Search for a W' or techni-ρ decaying into WZ in pp Collisions at sqrt[s] = 7  TeV. Phys Rev Lett (2012) 1.10

Multiple pathways underlying endothelium-dependent relaxation in the rabbit isolated femoral artery. Br J Pharmacol (1995) 1.10

Search for new physics with same-sign isolated dilepton events with jets and missing transverse energy. Phys Rev Lett (2012) 1.09

Human sweat components attractive to mosquitoes. Nature (1965) 1.09

Aspergillus in pepper. Lancet (1990) 1.08

Surfactant phospholipids and lavage phospholipase A2 in experimental Pneumocystis carinii pneumonia. Am Rev Respir Dis (1986) 1.08

Percutaneous transthoracic needle aspiration of the lung. Diagnosing Pneumocystis carinii pneumonitis. Am J Dis Child (1977) 1.08

Search for supersymmetry at the LHC in events with jets and missing transverse energy. Phys Rev Lett (2011) 1.08

Infection during induction of remission in acute lymphocytic leukemia. Cancer (1973) 1.07

Search for stopped Gluinos in pp collisions at square root s=7 TeV. Phys Rev Lett (2011) 1.07

Molecular and genealogical evidence for a founder effect in Fanconi anemia families of the Afrikaner population of South Africa. Proc Natl Acad Sci U S A (2001) 1.07

A rapid staining technique for Pneumocystis carinii. J Clin Pathol (1972) 1.06

Mycoflora in cystic fibrosis: some ecologic aspects of Pseudomonas aeruginosa and Candida albicans. Mycopathol Mycol Appl (1973) 1.05

Repeat attenders at National Health Service walk-in centres - a descriptive study using routine data. Public Health (2009) 1.05

Measurement of the Υ1S, Υ2S, and Υ3S polarizations in pp collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2013) 1.05

Systemic candidiasis: a study of 109 fatal cases. Pediatr Infect Dis (1983) 1.04

Experimental Pneumocystis carinii pneumonia in the ferret. Br J Exp Pathol (1987) 1.04

Search for Pneumocystis carinii DNA in upper and lower respiratory tract of humans. Diagn Microbiol Infect Dis (2000) 1.03

Editorial: Treatment of Pneumocystis carinii pneumonitis. N Engl J Med (1976) 1.03

Fusion of T and B cells. Somatic Cell Genet (1977) 1.03

Pneumocystis carinii pneumonitis. N Engl J Med (1987) 1.02

Comparison of methods for identification of Pneumocystis carinii in pulmonary aspirates. Am J Clin Pathol (1973) 1.02

C-reactive protein in spinal fluid of children with meningitis. J Pediatr (1981) 1.02

Cytomegaloviremia in children with acute lymphocytic leukemia. J Pediatr (1975) 1.02

Cardiovascular disease in African American and white physicians: the Meharry Cohort and Meharry-Hopkins Cohort Studies. J Health Care Poor Underserved (1997) 1.02

Dapsone treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Antimicrob Agents Chemother (1988) 1.02

Pneumocystis carinii pneumonitis in young immunocompetent infants. Pediatrics (1980) 1.00

Oral cefixime is similar to continued intravenous antibiotics in the empirical treatment of febrile neutropenic children with cancer. Clin Infect Dis (2000) 1.00

DNA amplification of nasopharyngeal aspirates in rats: a procedure to detect Pneumocystis carinii. Microb Pathog (1999) 1.00

Provocation of infection due to Pneumocystis carinii by cyclosporin A. J Infect Dis (1982) 0.99

Measurement of the polarization of W bosons with large transverse momenta in W + jets events at the LHC. Phys Rev Lett (2011) 0.99